The efficacy of treatment of addition in Alzheimer's disease: Rationale for combination therapy with Galantamine and Memantine

被引：0
|
作者：
Zarra, Julio [1 ]
Schmidt, L. [2 ]
机构：
[1] Hosp Italiano La Plata, La Plata, Buenos Aires, Argentina
[2] Hosp Centenario, Gualeguaychu, Entre Rios, Argentina
来源：
INTERNATIONAL PSYCHOGERIATRICS | 2011年 / 23卷
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：S301 / S302
页数：2
相关论文
共 50 条
  • [31] Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia
    Maju Mathew Koola
    Samir Kumar Praharaj
    Anilkumar Pillai
    Current Behavioral Neuroscience Reports, 2019, 6 : 37 - 50
  • [32] Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia
    Koola, Maju Mathew
    Praharaj, Samir Kumar
    Pillai, Anilkumar
    CURRENT BEHAVIORAL NEUROSCIENCE REPORTS, 2019, 6 (02) : 37 - 50
  • [33] Four-year safety and efficacy of galantamine in the treatment of Alzheimer's disease
    Burns, A.
    Pirttila, T.
    Gold, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 42 - 43
  • [34] Efficacy of galantamine in treatment of Alzheimer's disease: an update meta-analysis
    Zhang, Xiaoli
    Shao, Junhui
    Wei, Yawei
    Zhang, Hui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (04): : 7423 - 7430
  • [35] Galantamine hydrobromide in a treatment of Alzheimer's disease
    Nikolova, G
    Yancheva, S
    Raychev, I
    Dobreva, D
    Traykov, L
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S96 - S96
  • [36] Galantamine efficacy in individuals with severe Alzheimer's disease
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (04) : 351 - 351
  • [37] Efficacy of memantine in moderate to severe Alzheimer's disease
    Wilkinson, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 318 - 318
  • [38] Preclinical basis for the efficacy of memantine in Alzheimer's disease
    Banerjee, PK
    Lahiri, DK
    Tanila, H
    Miguel-Hidalgo, JJ
    Iqbal, K
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S572 - S572
  • [39] The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease
    Loveman, E
    Green, C
    Kirby, J
    Takeda, A
    Picot, J
    Payne, E
    Clegg, A
    HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (01) : III - +
  • [40] Evaluation of memantine for the treatment of Alzheimer's disease
    Ferris, SH
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (12) : 2305 - 2313
12345